Silver carboxylate-TiO2/polydimethyl siloxane is a safe and effective antimicrobial with significant wound care potential

AbstractIntroduction:With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and...

Full description

Saved in:
Bibliographic Details
Published inOTA international : the open access journal of orthopaedic trauma Vol. 7; no. 2S; p. e299
Main Authors Allu, Sai, Whitaker, Colin, Stone, Benjamin, Vishwanath, Neel, Clippert, Drew, Jouffroy, Elia, Antoci, Valentin, Born, Christopher, Garcia, Dioscaris R.
Format Journal Article
LanguageEnglish
Published Maryland, MD Wolters Kluwer 01.03.2024
Subjects
Online AccessGet full text
ISSN2574-2167
2574-2167
DOI10.1097/OI9.0000000000000299

Cover

Abstract AbstractIntroduction:With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts.Methods:Through an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose-response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests.Results:The silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations.Discussion/Clinical Relevance:Current antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment.
AbstractList AbstractIntroduction:With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts.Methods:Through an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose-response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests.Results:The silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations.Discussion/Clinical Relevance:Current antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment.
Introduction:. With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts. Methods:. Through an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose–response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests. Results:. The silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations. Discussion/Clinical Relevance:. Current antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment.
With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts.IntroductionWith the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts.Through an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose-response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests.MethodsThrough an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose-response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests.The silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations.ResultsThe silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations.Current antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment.Discussion/Clinical RelevanceCurrent antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment.
ArticleNumber e299
Author Allu, Sai
Born, Christopher
Stone, Benjamin
Whitaker, Colin
Garcia, Dioscaris R.
Jouffroy, Elia
Vishwanath, Neel
Clippert, Drew
Antoci, Valentin
Author_xml – sequence: 1
  givenname: Sai
  orcidid: 0000-0002-0288-4503
  surname: Allu
  fullname: Allu, Sai
  email: sai_allu@brown.edu
  organization: The Diane N. Weiss Center for Orthopaedic Research, Rhode Island Hospital, Providence, RI; and
– sequence: 2
  givenname: Colin
  surname: Whitaker
  fullname: Whitaker, Colin
  email: colin_whitaker@brown.edu
  organization: Warren Alpert Medical School of Brown University, Providence, RI
– sequence: 3
  givenname: Benjamin
  surname: Stone
  fullname: Stone, Benjamin
  email: benjamin_stone@brown.edu
  organization: Warren Alpert Medical School of Brown University, Providence, RI
– sequence: 4
  givenname: Neel
  surname: Vishwanath
  fullname: Vishwanath, Neel
  email: neel_vishwanath@brown.edu
  organization: Warren Alpert Medical School of Brown University, Providence, RI
– sequence: 5
  givenname: Drew
  surname: Clippert
  fullname: Clippert, Drew
  email: drew_clippert@alumni.brown.edu
  organization: The Diane N. Weiss Center for Orthopaedic Research, Rhode Island Hospital, Providence, RI; and
– sequence: 6
  givenname: Elia
  surname: Jouffroy
  fullname: Jouffroy, Elia
  email: elia_jouffroy@alumni.brown.edu
  organization: The Diane N. Weiss Center for Orthopaedic Research, Rhode Island Hospital, Providence, RI; and
– sequence: 7
  givenname: Valentin
  surname: Antoci
  fullname: Antoci, Valentin
  email: valentin_antoci@brown.edu
  organization: Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI
– sequence: 8
  givenname: Christopher
  surname: Born
  fullname: Born, Christopher
  email: christopher_born@brown.edu
  organization: Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI
– sequence: 9
  givenname: Dioscaris R.
  surname: Garcia
  fullname: Garcia, Dioscaris R.
  email: dioscaris_garcia@brown.edu
  organization: Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI
BookMark eNp9kktv3CAUha0qlZqm-QddeNnNJAYbMKuqivoYKdIsmq7RNVzGpNhMwZ6J_32ZTlQlbVU2vM75OHB5XZyNYcSieEuqK1JJcb1Zy6vqaaNSvijOKRPNihIuzp6MXxWXKd1nDZFSckbOi-Wr83uMpYbYhYfFw4SrO7eh17vgF-MGnPrFl8n58AAjli6VUCawWMJoSrQW9eT2x9nkBqdj6Bz48uCmPnu2o7NO563yEOYsz2dguQsTZjH4N8VLCz7h5WN_UXz79PHu5svqdvN5ffPhdqVrzuSqloTXVae10GiAcmYqazgK0LSpW921xlhGBDM8i6iVWhArdNtxMFZW2XtRrE9cE-Be7aIbIC4qgFO_FkLcKoiT0x5VQ-uMpB2TgjYNb6CtraSSddwwyVqSWezEmscdLAfw_jeQVOpYDhWcVH-WI_ven3y7uRvQ6PwCEfyzMM93RterbdgfkTUnrMqEd4-EGH7MmCY1uKTR-1yVMCeVU7ZUCiGPF25O0lyOlCLavzLmL_OvjO3Jdgh-wpi--_mAUfUIfur_b_0JzpTHAw
Cites_doi 10.1001/jama.2014.18614
10.1097/DSS.0000000000000375
10.1093/jac/dks284
10.2106/JBJS.M.01474
10.1016/j.watres.2008.12.002
10.2174/1566524019666190321113008
10.1016/j.msec.2014.12.072
10.1155/2013/674378
10.1089/sur.2017.220
10.3390/antibiotics11040486
10.1046/j.1472-765X.1997.00219.x
10.3390/molecules23071629
ContentType Journal Article
Copyright Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association.
Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association. 2024
Copyright_xml – notice: Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association.
– notice: Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association. 2024
DBID AAYXX
CITATION
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1097/OI9.0000000000000299
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
EISSN 2574-2167
ExternalDocumentID oai_doaj_org_article_42338c2b59724464a83f9295b6d59581
10.1097/oi9.0000000000000299
PMC10936150
10_1097_OI9_0000000000000299
OTAI-D-23-00045
Genre other
GroupedDBID 0R~
AAAAV
AAGIX
AAHPQ
AAIQE
AAMOA
AAQKA
AASCR
ABASU
ABDIG
ABVCZ
ABZZY
ACGFS
ACILI
ACLDA
ACNWC
ACXJB
ACZKN
ADGGA
ADHPY
ADPDF
AFBFQ
AFDTB
AFUWQ
AHOMT
AHQNM
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
BYPQX
DIWNM
EBS
EEVPB
ERAAH
FCALG
GNXGY
GQDEL
GROUPED_DOAJ
HLJTE
IKREB
IKYAY
M~E
OK1
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OXXIT
RLZ
RPM
TEORI
TSPGW
AAYXX
ACCJW
ADGHP
ADKSD
ADSXY
AHVBC
CITATION
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c3659-391630bcc7ceda265d0fd6e7ac2438cb8ddf5175d60bc2f9c71f7c8b6adf90163
IEDL.DBID UNPAY
ISSN 2574-2167
IngestDate Fri Oct 03 12:40:47 EDT 2025
Sun Oct 26 04:08:18 EDT 2025
Tue Sep 30 17:09:57 EDT 2025
Mon Sep 08 05:34:14 EDT 2025
Wed Oct 01 03:25:49 EDT 2025
Wed Apr 16 02:22:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2S
Keywords silver carboxylate
antimicrobial resistance
surgical site infections
cytotoxicity
Language English
License http://creativecommons.org/licenses/by/4.0
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
cc-by-nc-nd
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3659-391630bcc7ceda265d0fd6e7ac2438cb8ddf5175d60bc2f9c71f7c8b6adf90163
Notes Corresponding author. Address: Department of Orthopaedic Surgery, Rhode Island Hospital, 1 Hoppin St, Providence, RI 02903. E-mail address: dioscaris_garcia@brown.edu (D. R. Garcia).Supported by NIAIG grant R03AI159776 and by NIH/NIAID R25. This research also supported in part by the Diane C. Weiss Foundation, the Sipprelle Family Foundation, and the Foundation for Orthopaedic Trauma.We have no relevant conflicts of interest to disclose. Dr. Born is a Director and holds stock in BioIntraface and BI Medical. Dr. Garcia holds equity in BI Medical. We have no other relevant conflicts of interest to disclose.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-0288-4503
OpenAccessLink https://proxy.k.utb.cz/login?url=https://doi.org/10.1097/oi9.0000000000000299
PQID 2958297796
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_42338c2b59724464a83f9295b6d59581
unpaywall_primary_10_1097_oi9_0000000000000299
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10936150
proquest_miscellaneous_2958297796
crossref_primary_10_1097_OI9_0000000000000299
wolterskluwer_health_10_1097_OI9_0000000000000299
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20240301
PublicationDateYYYYMMDD 2024-03-01
PublicationDate_xml – month: 03
  year: 2024
  text: 20240301
  day: 01
PublicationDecade 2020
PublicationPlace Maryland, MD
PublicationPlace_xml – name: Maryland, MD
PublicationTitle OTA international : the open access journal of orthopaedic trauma
PublicationYear 2024
Publisher Wolters Kluwer
Publisher_xml – name: Wolters Kluwer
References Lee, Pottinger, Butler-Wu (R6) 2014; 96
Elkhatib, Khalil, Ashour (R2) 2019; 19
Liau, Read, Pugh (R7) 1997; 25
Tran, Kelley, Tran (R9) 2015; 49
Park, Kim, Kim (R8) 2009; 43
LeVavasseur, Zeller (R10) 2022; 11
Horner, Mawer, Wilcox (R4) 2012; 67
Aldabaldetrecu, Tamayo, Alarcon (R11) 2018; 23
Merkow, Hu, Chung (R1) 2015; 313
Echols, Graves, LeBlanc (R3) 2015; 41
Nakase, Fukushima, Yukawa (R5) 2018; 19
Tran, Tran, Jarrell (R12) 2013; 2013
Elkhatib (R2-20240807) 2019; 19
Liau (R7-20240807) 1997; 25
Nakase (R5-20240807) 2018; 19
Aldabaldetrecu (R11-20240807) 2018; 23
Echols (R3-20240807) 2015; 41
Horner (R4-20240807) 2012; 67
Tran (R9-20240807) 2015; 49
Park (R8-20240807) 2009; 43
Tran (R12-20240807) 2013; 2013
LeVavasseur (R10-20240807) 2022; 11
Merkow (R1-20240807) 2015; 313
Lee (R6-20240807) 2014; 96
References_xml – volume: 313
  start-page: 482
  year: 2015
  end-page: 495
  ident: R1
  article-title: Underlying reasons associated with hospital readmission following surgery in the United States
  publication-title: JAMA
– volume: 96
  start-page: 1447
  year: 2014
  end-page: 1450
  ident: R6
  article-title: Propionibacterium persists in the skin despite standard surgical preparation
  publication-title: J Bone Joint Surg Am
– volume: 43
  start-page: 1027
  year: 2009
  end-page: 1032
  ident: R8
  article-title: Silver-ion mediated reactive oxygen species generation affecting bactericidal activity
  publication-title: Water Res
– volume: 19
  start-page: 298
  year: 2018
  end-page: 302
  ident: R5
  article-title: Proprionibacterium acnes has low susceptibility to chlorhexidine gluconate
  publication-title: Surg Infect (Larchmt)
– volume: 67
  start-page: 2547
  year: 2012
  end-page: 2559
  ident: R4
  article-title: Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?
  publication-title: J Antimicrob Chemother
– volume: 19
  start-page: 286
  year: 2019
  end-page: 293
  ident: R2
  article-title: Integrons and antiseptic resistance genes mediate resistance of Acinetobacter baumannii and Pseudomonas aeruginosa isolates from intensive care unit patients with wound infections
  publication-title: Curr Mol Med
– volume: 41
  start-page: 667
  year: 2015
  end-page: 676
  ident: R3
  article-title: Role of antiseptics in the prevention of surgical site infections
  publication-title: Dermatol Surg
– volume: 2013
  start-page: 674378
  year: 2013
  ident: R12
  article-title: In vivo caprine model for osteomyelitis and evaluation of biofilm-resistant intramedullary nails
  publication-title: Biomed Res Int
– volume: 49
  start-page: 201
  year: 2015
  end-page: 209
  ident: R9
  article-title: Silver doped titanium dioxide-PDMS hybrid coating inhibits Staphylococcus aureus and Staphylococcus epidermidis growth on PEEK
  publication-title: Mater Sci Eng C Mater Biol Appl
– volume: 23
  start-page: 1629
  year: 2018
  ident: R11
  article-title: Stability of antibacterial silver carboxylate complexes against Staphylococcus epidermidis and their cytotoxic effects
  publication-title: Molecules
– volume: 11
  start-page: 486
  year: 2022
  ident: R10
  article-title: Antibiotic therapy for prosthetic joint infections: an overview
  publication-title: Antibiot (Basel)
– volume: 25
  start-page: 279
  year: 1997
  end-page: 283
  ident: R7
  article-title: Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions
  publication-title: Lett Appl Microbiol
– volume: 313
  start-page: 482
  year: 2015
  ident: R1-20240807
  article-title: Underlying reasons associated with hospital readmission following surgery in the United States
  publication-title: JAMA
  doi: 10.1001/jama.2014.18614
– volume: 41
  start-page: 667
  year: 2015
  ident: R3-20240807
  article-title: Role of antiseptics in the prevention of surgical site infections
  publication-title: Dermatol Surg
  doi: 10.1097/DSS.0000000000000375
– volume: 67
  start-page: 2547
  year: 2012
  ident: R4-20240807
  article-title: Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dks284
– volume: 96
  start-page: 1447
  year: 2014
  ident: R6-20240807
  article-title: Propionibacterium persists in the skin despite standard surgical preparation
  publication-title: J Bone Joint Surg Am
  doi: 10.2106/JBJS.M.01474
– volume: 43
  start-page: 1027
  year: 2009
  ident: R8-20240807
  article-title: Silver-ion mediated reactive oxygen species generation affecting bactericidal activity
  publication-title: Water Res
  doi: 10.1016/j.watres.2008.12.002
– volume: 19
  start-page: 286
  year: 2019
  ident: R2-20240807
  article-title: Integrons and antiseptic resistance genes mediate resistance of Acinetobacter baumannii and Pseudomonas aeruginosa isolates from intensive care unit patients with wound infections
  publication-title: Curr Mol Med
  doi: 10.2174/1566524019666190321113008
– volume: 49
  start-page: 201
  year: 2015
  ident: R9-20240807
  article-title: Silver doped titanium dioxide-PDMS hybrid coating inhibits Staphylococcus aureus and Staphylococcus epidermidis growth on PEEK
  publication-title: Mater Sci Eng C Mater Biol Appl
  doi: 10.1016/j.msec.2014.12.072
– volume: 2013
  start-page: 674378
  year: 2013
  ident: R12-20240807
  article-title: In vivo caprine model for osteomyelitis and evaluation of biofilm-resistant intramedullary nails
  publication-title: Biomed Res Int
  doi: 10.1155/2013/674378
– volume: 19
  start-page: 298
  year: 2018
  ident: R5-20240807
  article-title: Proprionibacterium acnes has low susceptibility to chlorhexidine gluconate
  publication-title: Surg Infect (Larchmt)
  doi: 10.1089/sur.2017.220
– volume: 11
  start-page: 486
  year: 2022
  ident: R10-20240807
  article-title: Antibiotic therapy for prosthetic joint infections: an overview
  publication-title: Antibiot (Basel)
  doi: 10.3390/antibiotics11040486
– volume: 25
  start-page: 279
  year: 1997
  ident: R7-20240807
  article-title: Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions
  publication-title: Lett Appl Microbiol
  doi: 10.1046/j.1472-765X.1997.00219.x
– volume: 23
  start-page: 1629
  year: 2018
  ident: R11-20240807
  article-title: Stability of antibacterial silver carboxylate complexes against Staphylococcus epidermidis and their cytotoxic effects
  publication-title: Molecules
  doi: 10.3390/molecules23071629
SSID ssj0001999651
Score 2.2511172
Snippet AbstractIntroduction:With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that...
With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized...
Introduction:. With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can...
SourceID doaj
unpaywall
pubmedcentral
proquest
crossref
wolterskluwer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e299
SubjectTerms Best Paper, Basic Science Forum, 2022 OTA Annual Meeting
Clinical/Basic Science
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLbQLiAhBAJEgCEjcQ1NndixjzAxbUiwA5u0W-RfERYhqZZWXf573nOarRkILvRQtY0ly-899322v_eZkHeQw2zhlUtr6WGB4kuTGgZvkHkcTCeX-bgP-eWrOLkoPl_yy72rvpATNsoDj4ZbQLrPpWUGgC9kIlFomdeQ0rkRjisei65ZJtXeYiruriCO58upVk6Vi7NTNWoVTi8W5V5vc1GU7J_hzLssyfubdqWHrW7g88Nth6fZ_Y9IZt9LScePyaMdlqQfxjE8Ifd8-5QM3wKSnanVV6a7HhrAkul5OGOLVdcMLuCN0UND-9B017r1NPRU017XnurW0ZHdAX-A8G0dfoao0gRd4G4tRaoHEovgEd3ibUzYh6erbo2MI908IxfHn86PTtLd_QqpzQVXKdbc5pmxtrTeaSa4y2onfKktK8DmRjpXc4AXTkAjVitbLuvSSiO0qwFGiPw5OWi71r8glFluwOKGc6dgxea0zLiR2itd1AAQZELSydLVapTRqKbjb_BMddczCfmI7rhpiyLY8QcIjWoXGtW_QiMhbydnVjBp8CQEDNtt-goaYUlxqURC5MzLsx7nT9rwPcpvowAXyugn5P1NQPw2qC78aVDLWdRUY6nrXw3x8n8Y4hV5wACLjdS51-RgfbXxh4Cl1uZNnDa_AB9OGRE
  priority: 102
  providerName: Directory of Open Access Journals
Title Silver carboxylate-TiO2/polydimethyl siloxane is a safe and effective antimicrobial with significant wound care potential
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.1097/OI9.0000000000000299
https://www.proquest.com/docview/2958297796
https://pubmed.ncbi.nlm.nih.gov/PMC10936150
https://doi.org/10.1097/oi9.0000000000000299
https://doaj.org/article/42338c2b59724464a83f9295b6d59581
UnpaywallVersion publishedVersion
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2574-2167
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001999651
  issn: 2574-2167
  databaseCode: DOA
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2574-2167
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001999651
  issn: 2574-2167
  databaseCode: M~E
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2574-2167
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001999651
  issn: 2574-2167
  databaseCode: RPM
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFD506cMGYxe2MW9r0WCPc5rY1u2xHS3doO1gDXRPRjdTU88OtUOa_voe2XGZswtbHkIcyxxLOpI-Sd_5BPABxzCTOGnDTDicoDiuQx3hF448FpuTnbh2HfLklB3Pki8X9GILPvaxMIP9e8n3qlx2EoP9B7vPB7DNKCLvEWzPTr_uf_fnx1GehNGU8T467g-PDkafVqR_gCw3eZEPF-VcrZaqwN-Pl5Xfv66vWvr6T4PQ0VM46V-_455cjReNHpvbDWXHf83fM3iyRqNkv3Of57Dlyhew-pZ7ujQx6lqjnQLRaHien0V786pY2dyfOb0qSJ0X1Y0qHclrokitMkdUaUnHD8EuFK-a_Efe6jyhCb_eSzxZxFOT8BZZ-vOcvA1H5lXjOUuqeAmzo8PzT8fh-oSG0MRYBaGP2o0n2hhunFURo3aSWea4MlESC6OFtRlFgGIZJooyafg040ZopmyGQITFr2BUVqV7DSQyVOPcS1NqJc75rBITqoVyUiUZQgwRQNjXXDrvhDjSfgP97LNMNwsxgANfvfdpvYx2-weWfrpulSliSXzNSOOsCmEOS5SIM8SLVDNLJRXTAN73zpFis_N7KViw1aJOMZEPSuaSBSAGXjOwOLxT5petgLeX8PJC_AGM7x3sl0yhZ_wmU9OBF6ZdsOxfC-LN_xp5C48iRG4d0e4djJrrhdtB5NXo3XbFYnfd7O4AVZYlpg
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFD6ssw8K4gUV640IPtrZmbRJk8dVXFZhdwV3YH0quWLZ2g7bDuP46z1pp4sdL2gfSi8pp0lOmi_Nd74AvMI-zKRO2tgLhwMUl-lYU9xhz2OxOdmZ6_5Dnpzy40X64YJd7MHrIRZmNH8vs4O6kL3E4LDh5_MG7HOGyHsC-4vTj4efw_pxLEtjOufZEB33h0dHvU8n0j9Clru8yJuraqk2a1Xi8e11Heavm8uOvv5TJ3R0F06G1--5J5fTVaun5vuOsuO_5u8e3NmiUXLYu8992HPVA9h8KgJdmhh1pdFOiWg0Pi_O6MGyLje2CGtOb0rSFGX9TVWOFA1RpFHeEVVZ0vND8BOKZ23xteh0ntBE-N9LAlkkUJPwFlmH9ZyCDUeWdRs4S6p8CIujd-dvj-PtCg2xSbAK4hC1m8y0MZlxVlHO7Mxb7jJlaJoIo4W1niFAsRwTUS9NNveZEZor6xGI8OQRTKq6co-BUMM0jr00Y1bimM8qMWNaKCdV6hFiiAjioebyZS_EkQ8T6GfvZb5biBG8CdV7nTbIaHcXsPTzbavMEUvia1KNoyqEOTxVIvGIF5nmlkkm5hG8HJwjx2YX5lKwYOtVk2OiEJScSR6BGHnNyOL4TlV86QS8g4RXEOKPYHrtYL9kCj3jN5maj7ww74Nl_1oQT_7XyFO4RRG59US7ZzBpr1buOSKvVr_YNrgfeW4ksQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Silver+carboxylate-TiO2%2Fpolydimethyl+siloxane+is+a+safe+and+effective+antimicrobial+with+significant+wound+care+potential&rft.jtitle=OTA+international+%3A+the+open+access+journal+of+orthopaedic+trauma&rft.au=Allu%2C+Sai&rft.au=Whitaker%2C+Colin&rft.au=Stone%2C+Benjamin&rft.au=Vishwanath%2C+Neel&rft.date=2024-03-01&rft.issn=2574-2167&rft.eissn=2574-2167&rft.volume=7&rft.issue=2S&rft_id=info:doi/10.1097%2FOI9.0000000000000299&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_OI9_0000000000000299
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2574-2167&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2574-2167&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2574-2167&client=summon